Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Genetic Characterization of Marginal Zone Lymphomas in Tissue and cfDNA

Ramón Diez-Feijóo Varela, Marta Lafuente, Nieves Garcia-Gisbert, Concepción Fernández-Rodríguez, Blanca Sánchez-González, Joan Gibert, Lierni Fernández-Ibarrondo, Laura Camacho, Raquel Longarón, Luis Colomo, Ana Ferrer, Christelle Ferrà, Marta Salido, Antonio Salar, Beatriz Bellosillo

Blood (2024) 144 (Supplement 1): 4351.

https://doi.org/10.1182/blood-2024-210085

Published: 2024

Journal Articles

Multi-Omics Exploration of Adaptive Mechanism to BTK Inhibition By Ibrutinib in CLL Identified TMBIM6/BI-1 As a Poor Prognosis Variable and Potential Therapeutic Target

Daniel Medina, Laura Palomo, Víctor Navarro, Oriol Castells, Belén Sánchez, Pau Marc Muñoz Torres, Carlota Pagès Geli, Cristina Hernández, Gemma Pujadas, Alba Cabirta Touzón, Christelle Ferrà, Miguel Alcoceba, María José Terol, Rafael Andreu, Francesc Bosch, Pau Abrisqueta, Marta Crespo

Blood (2023) 142 (Supplement 1): 3254.

https://doi.org/10.1182/blood-2023-185683

Published: 2023

Journal Articles

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Blood (2022) 140 (Supplement 1): 9908–9910.

https://doi.org/10.1182/blood-2022-162186

Published: 2022

Journal Articles

Ruxolitinib in Acute and Chronic Graft-Versus-Host Disease: Real Life Experience in a Multi-Centre Study

Blood (2022) 140 (Supplement 1): 7754–7756.

https://doi.org/10.1182/blood-2022-164561

Published: 2022

Journal Articles

Role of Allogeneic Hematopoietic Cell Transplant for Relapsed/Refractory Large B-Cell Lymphomas in the CART Era

Blood (2022) 140 (Supplement 1): 665–667.

https://doi.org/10.1182/blood-2022-160000

Published: 2022

Journal Articles

Viral-Specific T Cell Therapy for Cytomegalovirus Infection after Stem Cell Transplantation and Generation of a Third-Party T-Cell Donor Registry

Pere Barba, Elisa Roldan, María Suárez-Lledó, Juan Montoro Gomez, Santiago Perez-Hoyos, Alberto Mussetti, Christelle Ferra, Ruth Coll, Luciano Rodriguez, Julia Marsal, Rodrigo Martino, Julio Castaño, Marga Codinach, Francesc Bosch, Ramon Gimeno, David Valcarcel, Francesc Rudilla, Sergio Querol

Blood (2022) 140 (Supplement 1): 10309–10310.

https://doi.org/10.1182/blood-2022-165943

Published: 2022

Journal Articles

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real -World Setting in Spain: The Venares Study

Blood (2021) 138 (Supplement 1): 1561.

https://doi.org/10.1182/blood-2021-147685

Published: 2021

Journal Articles

Influence of Donor Type, Stem Cell Source and Conditioning Regimen on Transplant Outcomes after Haploidentical Transplant with Post Transplant Cyclophosphamide for Lymphoma: A Report of the EBMT Lymphoma Working Party

Blood (2018) 132 (Supplement 1): 484.

https://doi.org/10.1182/blood-2018-99-111674

Published: 2018

Journal Articles

Clinical Outcome and Prognostic Factors of Patients with Richter's Syndrome: Retrospective Multicenter Study of the Spanish Chronic Lymphocytic Leukemia (CLL) Study Group (GELLC)

Pau Abrisqueta, MD PhD, Julio Delgado, MD, Miguel Alcoceba, PhD, Marcos González, MD, Ana C Oliveira, MD PhD, Javier Loscertales, MD, Jose Angel Hernandez-Rivas, Christelle Ferra, Raul Cordoba, MD PhD, Lucrecia Yañez, MD, Angeles Medina, MD, Cristina Motllo, Anna Varela, Francesc Bosch

Blood (2017) 130 (Supplement 1): 2995.

https://doi.org/10.1182/blood.V130.Suppl_1.2995.2995

Published: 2017

Journal Articles

Prophylaxis with ATLG Significantly Improves Chronic Graft-Versus-Host Disease / Relapse-Free Survival and Quality of Life after a Myeloablative HLA Identical Sibling Transplant for Acute Leukemia Patients in Complete Remission. Long-Term Follow-up of the Randomized ATG Familystudy

Blood (2017) 130 (Supplement 1): 519.

https://doi.org/10.1182/blood.V130.Suppl_1.519.519

Published: 2017

Journal Articles

Impact of Refined Disease Risk Index after Single and Double Umbilical Cord Blood Transplantation in Adults with Hematological Malignancies

Annalisa Paviglianiti, MD, Annalisa Ruggeri, MD, Guillermo Sanz, MD, Noel Milpied, MD, Didier Blaise, MD PhD, Albert Esquirol, MD, William Arcese, Christelle Ferra, Norbert Ifrah, Jean Henri Bouris, Kavita Raj, Joan Hendrik Veelken, MD PhD, Simona Sica, Nathalie Contentin, Adrian Bloor, Fernanda Volt, MT, Chantal Kenzey, Vanderson Rocha, MD PhD, Eliane Gluckman, MD PhD

Blood (2016) 128 (22): 3484.

https://doi.org/10.1182/blood.V128.22.3484.3484

Published: 2016

Journal Articles

Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy)

Blood (2014) 124 (21): 37.

https://doi.org/10.1182/blood.V124.21.37.37

Published: 2014

Journal Articles

Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

Blood (2013) 122 (24): 3951–3959.

https://doi.org/10.1182/blood-2013-05-502773

Published: 2013

Includes: Supplemental data

Journal Articles

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Reduced Intensity Conditioning (RIC) Regimens and High Dose Cylophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In Patients With Relapsed Or Refractory Hodgkin´s Disease: Multicentric Spanish Experience

Jorge Gayoso, MD, Pascual Balsalobre, MSc, Cristina Castilla-Llorente, MD, María Jesús Pascual, MD, Mi Kwon, MD, David Serrano, MD, Dolores Caballero, MD, PhD, Jose Antonio Pérez-Simón, Arancha Bermudez, MD, Carmen Martínez, MD, Cristina Pascual, MD, Inmaculada Heras, Carlos Solano, Angela Figuera, MD, Antonia Sampol, MD, PhD, Christelle Ferra, MD, Pilar Herrera, Ismael Buno, PhD, Jose Luis Diez-Martin, MD, PhD

Blood (2013) 122 (21): 3406.

https://doi.org/10.1182/blood.V122.21.3406.3406

Published: 2013

Journal Articles

Validation Of a Comprehensive Health Status Assessment Scale In Older Patients (≥ 65 years) With Hematological Malignances. Gah Study

Blood (2013) 122 (21): 2979.

https://doi.org/10.1182/blood.V122.21.2979.2979

Published: 2013

Journal Articles

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With High Dose Cyclophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In High Risk Hematologic Malignancies: Multicentric Spanish Experience

Blood (2013) 122 (21): 2173.

https://doi.org/10.1182/blood.V122.21.2173.2173

Published: 2013

Journal Articles

Prospective Study of Oral Valganciclovir for Pre-Emptive Therapy of Cytomegalovirus After Allogeneic Stem Cell Transplantation.

Rafael De La Camara, MD, Lourdes Vazquez, Javier Lopez, Carlos Solano, MD, PhD, David Serrano, MD, Ana Gracia-Noblejas, Josep-Maria Ribera, MD, PhD, Christelle Ferra

Blood (2009) 114 (22): 1168.

https://doi.org/10.1182/blood.V114.22.1168.1168

Published: 2009

Journal Articles

KIR-Ligand Incompatibility in the Graft-Versus-Host Direction Is Associated with Better Outcomes after Unrelated Cord Blood Stem Cell Transplantation for Acute Leukemia in Complete Remission

Blood (2008) 112 (11): 156.

https://doi.org/10.1182/blood.V112.11.156.156

Published: 2008

Journal Articles

Frequency and prognosis of Clonal Chromosomal Abnormalities Following Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML)

Blood (2008) 112 (11): 4309.

https://doi.org/10.1182/blood.V112.11.4309.4309

Published: 2008

Journal Articles

Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source.

Blood (2008) 112 (11): 969.

https://doi.org/10.1182/blood.V112.11.969.969

Published: 2008

NARROW

Genetic Characterization of Marginal Zone Lymphomas in Tissue and cfDNA

Multi-Omics Exploration of Adaptive Mechanism to BTK Inhibition By Ibrutinib in CLL Identified TMBIM6/BI-1 As a Poor Prognosis Variable and Potential Therapeutic Target

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Ruxolitinib in Acute and Chronic Graft-Versus-Host Disease: Real Life Experience in a Multi-Centre Study

Role of Allogeneic Hematopoietic Cell Transplant for Relapsed/Refractory Large B-Cell Lymphomas in the CART Era

Viral-Specific T Cell Therapy for Cytomegalovirus Infection after Stem Cell Transplantation and Generation of a Third-Party T-Cell Donor Registry

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real -World Setting in Spain: The Venares Study

Influence of Donor Type, Stem Cell Source and Conditioning Regimen on Transplant Outcomes after Haploidentical Transplant with Post Transplant Cyclophosphamide for Lymphoma: A Report of the EBMT Lymphoma Working Party

Clinical Outcome and Prognostic Factors of Patients with Richter's Syndrome: Retrospective Multicenter Study of the Spanish Chronic Lymphocytic Leukemia (CLL) Study Group (GELLC)

Prophylaxis with ATLG Significantly Improves Chronic Graft-Versus-Host Disease / Relapse-Free Survival and Quality of Life after a Myeloablative HLA Identical Sibling Transplant for Acute Leukemia Patients in Complete Remission. Long-Term Follow-up of the Randomized ATG Familystudy

Impact of Refined Disease Risk Index after Single and Double Umbilical Cord Blood Transplantation in Adults with Hematological Malignancies

Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy)

Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Reduced Intensity Conditioning (RIC) Regimens and High Dose Cylophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In Patients With Relapsed Or Refractory Hodgkin´s Disease: Multicentric Spanish Experience

Validation Of a Comprehensive Health Status Assessment Scale In Older Patients (≥ 65 years) With Hematological Malignances. Gah Study

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With High Dose Cyclophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In High Risk Hematologic Malignancies: Multicentric Spanish Experience

Prospective Study of Oral Valganciclovir for Pre-Emptive Therapy of Cytomegalovirus After Allogeneic Stem Cell Transplantation.

KIR-Ligand Incompatibility in the Graft-Versus-Host Direction Is Associated with Better Outcomes after Unrelated Cord Blood Stem Cell Transplantation for Acute Leukemia in Complete Remission

Frequency and prognosis of Clonal Chromosomal Abnormalities Following Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML)

Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only